News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Appoints Colleen Pelton Chief Talent Officer

Global Talent Executive to Advance Company’s Commitment to a Best-in-class Workforce

Veristat Announces New Investment Partner—WindRose Health Investors

Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of Patients

Veristat Congratulates Origin Biosciences for FDA Approval

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare Disease Day 2021

Veristat Expands Biometrics Capabilities by Acquiring SQN Clinical

Builds on a shared pedigree of data management, statistics and programming excellence across all phases of clinical trials

SOUTHBOROUGH, MA...

Veristat Supported Marketing Applications for 10% of all FDA Novel Drug Approvals in 2020

Strengthening its Track Record of Successful Client Regulatory Approval Outcomes

SOUTHBOROUGH, MA – January 14, 2021 – Veristat, a...

Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice...

Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe

Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook

Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials

SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a...

Veristat Expands Pharmacovigilance and Safety Services with Acquisition of Certus PV

Delivering on Customer Demand for Pharmacovigilance from Clinical Trial Conduct to Post-Marketing Support

Veristat Announces Global Cell and Gene Therapy Center of Excellence

Accelerating cell and gene therapy opportunities for patients by advancing access to knowledge and leveraging experience for sponsors to...